Evidence map›Paper›PMID 41630198›Full record

ArticleAdvanced healthcare materials2026

Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small-Caliber Vascular Grafts: A Multi-Layered Strategy Combining Electrospinning and 4-Axis Printing.

Gabriele Obino, Alberto Sensini, Tim Ten Brink, Gabriele Nieddu, Tristan Bodet, Giovanni Andrea Deiana, Martijn van Griensven, Marilena Formato, Antonio J Lepedda, Lorenzo Moroni

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriele ObinoDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0002-3192-755X
Alberto SensiniDepartment of Complex Tissue Regeneration MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0003-0681-5887
Tim Ten BrinkDepartment of Complex Tissue Regeneration MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0009-0006-9411-777X
Gabriele NiedduDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0002-9268-9436
Tristan BodetDepartment of Complex Tissue Regeneration MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
Giovanni Andrea DeianaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0002-6426-6647
Martijn van GriensvenDepartment of Cell Biology-Inspired Tissue Engineering MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0001-5104-9881
Marilena FormatoDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0001-9207-5787
Antonio J LepeddaDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0002-8356-894X
Lorenzo MoroniDepartment of Complex Tissue Regeneration MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0003-1298-6025

Funding

European Union - NextGenerationEUH2020 Marie Skłodowska-Curie Actions 101061826Horizon 2020 Framework Programme J55F21004240001Nederlandse Organisatie voor Wetenschappelijk Onderzoek 18647
6 · The paper itself

Abstract

The development of small-caliber tissue-engineered vascular grafts (sTEVGs) presents several challenges, including achieving balanced endothelialization, facilitating smooth muscle cell infiltration, preventing leakage, and ensuring anti-thrombogenic properties, while maintaining mechanical strength sufficient to withstand physiological pressures, surgical handling, and suturing. Here, we present a multi-layered polycaprolactone (PCL)-based sTEVG using a combination of electrospinning and 4-axis printing, providing precise control over scaffold porosity, fiber alignment, and tunable mechanical properties. To improve biocompatibility and hemocompatibility, the PCL nanofibers were functionalized with sulfated polysaccharides purified from the marine invertebrate Holothuria tubulosa, which significantly enhanced endothelialization and provided strong anti-thrombogenic properties. The inner layer of tightly aligned electrospun nanofibers supported rapid formation of a mature endothelium, while preventing graft leakage even at supraphysiological pressure (>1100 mmHg). The middle layers, combining circumferential electrospun nanofibers and 4-axis printed microfibers, increased scaffold porosity, and promoted adhesion, orientation and infiltration of human coronary artery smooth muscle cells (HCASMCs), facilitating functional tunica media formation. The outer layer of randomly oriented electrospun nanofibers contributed significantly to the mechanical properties of the graft, namely elasticity, toughness, burst pressure, and resistance to physiological vessel pressures, thus mimicking the tunica adventitia. The customizable four-layered graft integrates structural and biological cues to address key limitations of sTEVGs, representing a valuableoff-the-shelf alternative to autologous grafts.

Indexed as

Absorbable ImplantsBlood Vessel ProsthesisPolysaccharidesTissue ScaffoldsAnimalsBiocompatible MaterialsHumansMyocytes, Smooth MuscleNanofibersPolyestersPorositySulfatesTissue EngineeringBiocompatible MaterialspolycaprolactonePolyestersPolysaccharidesSulfates4‐Axis printingelectrospinningendothelializationmarine sulfated polysaccharidessmall‐caliber tissue‐engineered vascular grafts

Identifiers

PMID41630198
PMCPMC13107931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.